Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy
Condition:  Buruli Ulcer Interventions:  Drug: Standard [RC8]: rifampicin plus clarithromycin (RC) therapy for 8 weeks.;  Drug: Investigational [RCA4]: standard (RC) plus amoxicillin/clavulanate (A) for 4 weeks. Sponsors:  Fundacion Agencia Aragonesa para la Investigacion y Desarrollo (ARAID);  Universidad de Zaragoza;  Fondation Raoul Follereau;  Université d'Abomey-Calavi;  Instituto de Salud Carlos III;  Fundación Anesvad Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials